Medtronicvs.Zimmer Biomet
MDT vs ZBH · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Medtronic is about 6.5× larger than Zimmer Biomet by market cap; year to date, Zimmer Biomet leads (−1.6% vs −11.0%).
Side by side
| MDT | ZBH | |
|---|---|---|
| Market cap | $112B | $17.3B |
| Price | $87.75 | $88.88 |
| Today | +2.6% | +0.4% |
| Return YTD | −11.0% | −1.6% |
| Return 1Y | −13.0% | −10.7% |
| Since June 26, 2026 | +8.4% | −4.5% |
| P/E | 21.3 | 21.5 |
| P/S | 3.0 | 2.0 |
| P/B | 2.2 | 1.4 |
Data as of 2026-10-08 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
MedtronicMDT
Cardiac rhythm and cardiology devices anchor a catalogue that also runs through surgical equipment, neurology and diabetes treatment.
Full MDT profile →More MDT & ZBH comparisons
Other head-to-heads in the Medtech & devices segment.
See where MDT and ZBH sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →